MiRNA-199a-3p in Plasma as a Potential Diagnostic Biomarker for Gastric Cancer
暂无分享,去创建一个
Min Yan | Qu Cai | Jian Fang Li | Chen Li | Q. Cai | M. Yan | Q. Qiu | Chen Li | Zheng Gang Zhu | Qing Qing Qiu | Bing Ya Liu | J. Li | Bing-ya Liu | Zheng‐gang Zhu
[1] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[2] Jian Li,et al. miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. , 2010, Biological & pharmaceutical bulletin.
[3] Tao Yu,et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster , 2009, Journal of experimental & clinical cancer research : CR.
[4] L. Martins,et al. CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia. , 2007, Arquivos de gastroenterologia.
[5] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[6] Chien-Jen Chen,et al. Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan , 2005, Cancer Epidemiology Biomarkers & Prevention.
[7] C. Haglund,et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. , 2002, Anticancer research.
[8] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[9] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[10] H. Bonnefoi,et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] Xiaohua Li,et al. Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.
[12] C. Croce,et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. , 2010, Cancer research.
[13] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[14] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[15] S. Leung,et al. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. , 1999, Clinical chemistry.
[16] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[17] R. Soetikno,et al. Endoscopic submucosal dissection of early gastric cancer , 2006, Journal of Gastroenterology.
[18] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[19] George A Calin,et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.
[20] Xi Chen,et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.
[21] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[22] Li Lin,et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.
[23] Liu Hong,et al. miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells , 2008, International journal of cancer.
[24] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[25] Jacques Ferlay,et al. Estimates of cancer incidence in China for 2000 and projections for 2005. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[26] Y. Lo,et al. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] G. Gerken,et al. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion , 2010, Molecular Cancer.